Freedom of information requests

FOI relating to Incidences and treatment of Colorectal cancer

Questions

In the past 3 months, how many patients have been treated for Colorectal Cancer [CRC] with the following regimens? If possible, please also provide the split of metastatic vs non-metastatic patients for each regimen.

Response

The Trust does hold all of the information you have requested, however we are withholding some of it for the following reasons:

Section 40 – Personal Information

Section 40 (2) of the Freedom of Information Act (2000) allows public authorities to withhold personal data where it is protected under the Data Protection Act.

“Personal data” means any information relating to an identified living individual.

We have therefore withheld the exact number of patients where this is 6 or less (replaced with the <6 symbol), as providing this could be potentially identifiable and as such is protected from disclosure by Section 40 (2) of the FOI Act.

Regimens	Total patients	Metastatic patients	Non-Metastatic patients
Capecitabine	<6	N/A	N/A
CAPIRI	0	N/A	N/A
CAPOX	0	N/A	N/A
Cetuximab with FOLFIRI	0	N/A	N/A
Cetuximab with FOLFOX	0	N/A	N/A
Cetuximab as a single agent	0	N/A	N/A
Cetuximab with Encorafenib	0	N/A	N/A
Irinotecan as a single agent	<6	N/A	N/A
FOLFIRI	0	N/A	N/A
FOLFOX	0	N/A	N/A
Fluorouracil (5FU) as a single agent	59	N/A	N/A
Oxaliplatin as a single agent	<6	N/A	N/A
Nivolumab with Ipilimumab	0	N/A	N/A
Panitumumab with FOLFIRI	0	N/A	N/A
Panitumumab with FOLFOX	0	N/A	N/A
Panitumumab as a single agent	0	N/A	N/A
Pembrolizumab	0	N/A	N/A
Any other systemic anti-cancer therapy	0	N/A	N/A
Palliative care only	0	N/A	N/A

Data correct at 20 January 2024.

We do not hold the information for the split of metastatic vs non-metastatic.